Trials / Conditions / Recurrent Gastroesophageal Junction Adenocarcinoma
Recurrent Gastroesophageal Junction Adenocarcinoma
4 registered clinical trials studyying Recurrent Gastroesophageal Junction Adenocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Ga NCT03918499 | City of Hope Medical Center | Phase 1 / Phase 2 |
| Completed | Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal NCT03008278 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Rec NCT02391038 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Active Not Recruiting | Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal NCT01142388 | National Cancer Institute (NCI) | Phase 2 |